logo

Adcock cashes in on SA’s flu bug

PUBLISHED: Wed, 21 Feb 2018 11:26:44 GMT

Share

JSE listed pharmaceutical company Adcock Ingram Group delivered interim results for six-months ended 31 December 2017 today, with an increase in headline earnings per share.


Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.

RELATED